Abstract: Provided herein are compounds of Formula (I), their pharmaceutically acceptable salts, and their pharmaceutical compositions: wherein R1, R2, R3a, R3b, R4, R5, and A are defined in the present disclosure. The compounds are potent inhibitors of the main protease (Mpro) of severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2), and they are useful in treating or preventing COVID-19 in a subject.

Abstract: Brain modelling includes receiving time-coded bio-signal data associated with a user; receiving time-coded stimulus event data; projecting the time-coded bio-signal data into a lower dimensioned feature space; extracting features from the lower dimensioned feature space that correspond to time codes of the time-coded stimulus event data to identify a brain response; generating a training data set for the brain response using the features; training a brain model using the training set, the brain model unique to the user; generating a brain state prediction for the user output from the trained brain model, and automatically computing similarity metrics of the brain model as compared to other user data; and inputting the brain state prediction to a feedback model to determine a feedback stimulus for the user, wherein the feedback model is associated with a target brain state.

Abstract: Brain modelling includes receiving time-coded bio-signal data associated with a user; receiving time-coded stimulus event data; projecting the time-coded bio-signal data into a lower dimensioned feature space; extracting features from the lower dimensioned feature space that correspond to time codes of the time-coded stimulus event data to identify a brain response; generating a training data set for the brain response using the features; training a brain model using the training set, the brain model unique to the user; generating a brain state prediction for the user output from the trained brain model, and automatically computing similarity metrics of the brain model as compared to other user data; and inputting the brain state prediction to a feedback model to determine a feedback stimulus for the user, wherein the feedback model is associated with a target brain state.

Abstract: Brain modelling includes receiving time-coded bio-signal data associated with a user; receiving time-coded stimulus event data; projecting the time-coded bio-signal data into a lower dimensioned feature space; extracting features from the lower dimensioned feature space that correspond to time codes of the time-coded stimulus event data to identify a brain response; generating a training data set for the brain response using the features; training a brain model using the training set, the brain model unique to the user; generating a brain state prediction for the user output from the trained brain model, and automatically computing similarity metrics of the brain model as compared to other user data; and inputting the brain state prediction to a feedback model to determine a feedback stimulus for the user, wherein the feedback model is associated with a target brain state.